Cite
HARVARD Citation
Wei, L. et al. (2019). Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia–Pacific region and Russia: Final results from the randomized C‐CORAL study. Journal of gastroenterology and hepatology. 34 (1), pp. 12-21. [Online].